Type 2 Diabetes Mellitus in Obese
24
3
3
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
1 terminated out of 24 trials
91.7%
+5.2% vs benchmark
17%
4 trials in Phase 3/4
36%
4 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (24)
Phentermine/Topiramate for Uric Acid Stones
REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults
Beta-Cell - Liver Interactions in Situations of Modified Beta-Cell Function
Implementation of a Peer Leader-facilitated Dyadic Intervention
Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences
A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
Effect of Cryolipolysis on Insulin Resistance
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP
The Effect of Exenatide on Fasting Bile Acids